Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment.


Journal

Deutsches Arzteblatt international
ISSN: 1866-0452
Titre abrégé: Dtsch Arztebl Int
Pays: Germany
ID NLM: 101475967

Informations de publication

Date de publication:
24 May 2019
Historique:
received: 14 01 2019
revised: 14 01 2019
accepted: 06 05 2019
entrez: 19 7 2019
pubmed: 19 7 2019
medline: 9 6 2020
Statut: ppublish

Résumé

Pleural effusion is common in routine medical practice and can be due to many different underlying diseases. Precise differential diagnostic categorization is essential, as the treatment and prognosis of pleural effusion largely depend on its cause. This review is based on pertinent publications retrieved by a selective search in PubMed and on the authors' personal experience. The most common causes of pleural effusion are congestive heart failure, cancer, pneumonia, and pulmonary embolism. Pleural fluid puncture (pleural tap) enables the differentiation of a transudate from an exudate, which remains, at present, the foundation of the further diagnostic work-up. When a pleural effusion arises in the setting of pneumonia, the potential devel- opment of an empyema must not be overlooked. Lung cancer is the most common cause of malignant pleural effusion, followed by breast cancer. Alongside the treatment of the underlying disease, the specific treatment of pleural effusion ranges from pleurodesis, to thoracoscopy and video-assisted thoracoscopy (with early consultation of a thoracic surgeon), to the placement of a permanently indwelling pleural catheter. The proper treatment of pleural effusion can be determined only after meticulous differential diagnosis. The range of therapeutic options has recently become much wider. More data can be expected in the near future concerning diagnostic test- ing for the etiology of the effusion, better pleurodetic agents, the development of interventional techniques, and the genetic background of the affected patients.

Sections du résumé

BACKGROUND BACKGROUND
Pleural effusion is common in routine medical practice and can be due to many different underlying diseases. Precise differential diagnostic categorization is essential, as the treatment and prognosis of pleural effusion largely depend on its cause.
METHODS METHODS
This review is based on pertinent publications retrieved by a selective search in PubMed and on the authors' personal experience.
RESULTS RESULTS
The most common causes of pleural effusion are congestive heart failure, cancer, pneumonia, and pulmonary embolism. Pleural fluid puncture (pleural tap) enables the differentiation of a transudate from an exudate, which remains, at present, the foundation of the further diagnostic work-up. When a pleural effusion arises in the setting of pneumonia, the potential devel- opment of an empyema must not be overlooked. Lung cancer is the most common cause of malignant pleural effusion, followed by breast cancer. Alongside the treatment of the underlying disease, the specific treatment of pleural effusion ranges from pleurodesis, to thoracoscopy and video-assisted thoracoscopy (with early consultation of a thoracic surgeon), to the placement of a permanently indwelling pleural catheter.
CONCLUSION CONCLUSIONS
The proper treatment of pleural effusion can be determined only after meticulous differential diagnosis. The range of therapeutic options has recently become much wider. More data can be expected in the near future concerning diagnostic test- ing for the etiology of the effusion, better pleurodetic agents, the development of interventional techniques, and the genetic background of the affected patients.

Identifiants

pubmed: 31315808
pii: arztebl.2019.0377
doi: 10.3238/arztebl.2019.0377
pmc: PMC6647819
doi:
pii:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

377-386

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Chest. 2000 Jan;117(1):79-86
pubmed: 10631203
Thorax. 2004 Nov;59(11):960-5
pubmed: 15516472
Am J Respir Crit Care Med. 2006 Oct 1;174(7):817-23
pubmed: 16840746
Chest. 2009 Sep;136(3):688-693
pubmed: 19395582
Respir Med. 2010 Jan;104(1):1-8
pubmed: 19766473
Arch Intern Med. 2010 Feb 22;170(4):332-9
pubmed: 20177035
Thorax. 2010 Aug;65 Suppl 2:ii61-76
pubmed: 20696688
Thorax. 2010 Aug;65 Suppl 2:ii32-40
pubmed: 20696691
Thorax. 2010 Aug;65 Suppl 2:ii4-17
pubmed: 20696692
Thorax. 2010 Aug;65 Suppl 2:ii41-53
pubmed: 20696693
Eur Respir Rev. 2009 Dec;18(114):244-52
pubmed: 20956149
Sleep Breath. 2012 Jun;16(2):483-9
pubmed: 21573912
Thorax. 2011 Aug;66(8):663-8
pubmed: 21617169
Z Gastroenterol. 2011 Jun;49(6):749-79
pubmed: 21638242
Clin Infect Dis. 2011 Dec;53(12):1245-51
pubmed: 21976460
Respiration. 2012;83(1):5-12
pubmed: 22249151
Medicine (Baltimore). 2012 Mar;91(2):103-10
pubmed: 22391472
Arch Bronconeumol. 2014 May;50(5):161-5
pubmed: 24360987
Am Fam Physician. 2014 Jul 15;90(2):99-104
pubmed: 25077579
Thorax. 2014 Dec;69(12):1098-104
pubmed: 25100651
Curr Opin Pulm Med. 2015 Jul;21(4):338-45
pubmed: 25978627
Curr Opin Pulm Med. 2015 Jul;21(4):346-51
pubmed: 26016577
PLoS One. 2015 Aug 05;10(8):e0134376
pubmed: 26244664
Eur J Cardiothorac Surg. 2015 Nov;48(5):642-53
pubmed: 26254467
Pneumologie. 2016 Mar;70(3):151-200
pubmed: 26926396
Medicine (Baltimore). 2016 Mar;95(10):e3044
pubmed: 26962828
Ann Am Thorac Soc. 2016 Jul;13(7):1050-6
pubmed: 27064965
Cochrane Database Syst Rev. 2016 May 08;(5):CD010529
pubmed: 27155783
Chest. 2017 May;151(5):1099-1105
pubmed: 28025056
Respiration. 2017;93(4):271-278
pubmed: 28196360
Pneumologie. 2017 Jun;71(6):325-397
pubmed: 28651293
JAMA. 2017 Nov 21;318(19):1903-1912
pubmed: 29164255
Crit Care. 2017 Dec 28;21(1):325
pubmed: 29282107
N Engl J Med. 2018 Feb 22;378(8):740-751
pubmed: 29466146
N Engl J Med. 2018 Apr 5;378(14):1313-1322
pubmed: 29617585
Zentralbl Chir. 2018 Aug;143(S 01):S12-S43
pubmed: 30041262
Pneumologie. 2018 Dec;72(12):843-850
pubmed: 30071540
Ann Intern Med. 1972 Oct;77(4):507-13
pubmed: 4642731
Am J Respir Crit Care Med. 1995 Jun;151(6):1700-8
pubmed: 7767510

Auteurs

Berthold Jany (B)

Julius-Maximilians-Universität Würzburg, Klinikum Würzburg Mitte, Missioklinik, Department of Pneumology; Department of Respiratory Medicine, Hannover Medical School.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH